PHRRF (PharmaTher Holdings) Pretax Margin %: % (As of Feb. 2026)


What is PharmaTher Holdings Pretax Margin %?

PharmaTher Holdings PHRRF +4.75% Pretax Margin % is % as of Feb. 2026. The stock has 2 warning signs investors should review. Among 945 Biotechnology companies, PharmaTher Holdings ranks worse than 105820% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. PharmaTher Holdings's Pre-Tax Income for the three months ended in Feb. 2026 was $-0.00 Mil. PharmaTher Holdings's Revenue for the three months ended in Feb. 2026 was $0.00 Mil. Therefore, PharmaTher Holdings's pretax margin for the quarter that ended in Feb. 2026 was %.

The historical rank and industry rank for PharmaTher Holdings's Pretax Margin % or its related term are showing as below:


PHRRF's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.63
* Ranked among companies with meaningful Pretax Margin % only.

PharmaTher Holdings  (OTCPK:PHRRF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

PharmaTher Holdings Pretax Margin % Related Terms

PharmaTher Holdings Pretax Margin % Historical Data

* Premium members only.

The historical data trend for PharmaTher Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings Pretax Margin % Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23 May24 May25
Pretax Margin %
0.00 0.00 0.00 0.00 0.00

PharmaTher Holdings Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PHRRF vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, PharmaTher Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmaTher Holdings Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Pretax Margin % falls into.


PharmaTher Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

PharmaTher Holdings's Pretax Margin for the fiscal year that ended in May. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: May. 2025 )/Revenue (A: May. 2025 )
=-1.1/0
= %

PharmaTher Holdings's Pretax Margin for the quarter that ended in Feb. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Feb. 2026 )/Revenue (Q: Feb. 2026 )
=-0.001/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
PharmaTher Holdings (PHRRF) has a Pretax Margin % of % as of Feb. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PharmaTher Holdings and its competitors. According to the industry distribution chart, PharmaTher Holdings ranks #999999 out of 945 companies in the Biotechnology industry.
Is PharmaTher Holdings' Pretax Margin % too high?
PharmaTher Holdings' current Pretax Margin % is %. Based on the distribution chart, PharmaTher Holdings ranks #999999 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does PharmaTher Holdings' Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PharmaTher Holdings ranks #999999 out of 945 companies for Pretax Margin %. This places PharmaTher Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PharmaTher Holdings and its competitors. PharmaTher Holdings's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaTher Holdings stock overvalued right now?
PharmaTher Holdings (PHRRF) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For PharmaTher Holdings (PHRRF), the current Pretax Margin % is % as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaTher Holdings Business Description

Other Exchanges NCC0:GermanyPHRM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch and others.